Synthesis and cytotoxic activity of various 5-[alkoxy-(4-nitro-phenyl)-methyl]-uracils in their racemic form. 2007

Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
Department of Organic Chemistry, Faculty of Science, Palacký University, Tr. Svobody 8, 771 46 Olomouc, Czech Republic.

The preparation of various 5-[alkoxy-(4-nitro-phenyl)-methyl]-uracils with alkyl chain lengths C(1)-C(12) is described. The synthesis is based on the preparation of 5-[chloro-(4-nitro-phenyl)-methyl]-uracil and subsequent substitution of chlorine with appropriate alcohols. The resulting ethers were tested for their cytotoxic activity in vitro against five cancer cell lines. The compounds were less active in lung resistance protein expressing cell lines, suggesting the involvement of this multidrug resistant protein in control of the biological activity. Cytotoxic substances induced rapid inhibition of DNA and modulation of RNA synthesis followed by induction of apoptosis. The data indicate that the biological activity of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uracils depends on the alkyl chain length.

UI MeSH Term Description Entries
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000438 Alcohols Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562

Related Publications

Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
September 2010, European journal of medicinal chemistry,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
September 1983, Journal of medicinal chemistry,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
November 2009, Acta crystallographica. Section E, Structure reports online,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
October 2011, Acta crystallographica. Section E, Structure reports online,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
April 2021, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
July 1997, Journal of medicinal chemistry,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
October 2011, Acta crystallographica. Section E, Structure reports online,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
August 2008, Archiv der Pharmazie,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
January 2014, Acta crystallographica. Section E, Structure reports online,
Lucie Spácilová, and Petr Dzubák, and Marián Hajdúch, and Sona Krupková, and Pavel Hradil, and Jan Hlavác
March 2013, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!